General

                  Imiquimod-Induced Psoriasis Psoriasis is a chronic skin condition associated with multiple contributing factors including autoimmune disease. The imiquimod-induced Psoriasis model is particularly translational into the clinic as it has many of the significant markers of human disease, including histopathology of lesions and strong activation of the […]

A Model of Psoriasis Psoriasis is a chronic skin condition associated with multiple contributing factors including autoimmune disease. The imiquimod-induced Psoriasis model is particularly translational into the clinic as it has many of the significant markers of human disease, including histopathology of lesions and strong activation of the immune system. CBI’s extensive immunology expertise allows […]

Oncolytic Viral Vaccine Toxicology at CBI   Introduction to Toxicology. “Oncolytic viral therapy is a new promising strategy against cancer. Oncolytic viruses (OVs) can replicate in cancer cells but not in normal cells, leading to lysis of the tumor mass.” Background. Oncolytic viral vaccines represents a novel and exciting approach to the treatment of cancer. In 2015, […]

            Surgical Procedure: ↑ Lens phakoemulsion to remove lens, insertion of “Intraocular Lens Implantation” and final appearance of successfully implanted IOL.   Intraocular Lens Implantation Preclinical Models at CBI An intraocular lens implant is a synthetic, artificial lens placed inside the eye that replaces the focusing power of a natural lens […]

        Pompe Disease Pompe’s Disease or Glycogen Storage Disease II, is a rare, inherited fatal disease affecting infants. It is an autosomal recessive metabolic disorder which damages muscle and nerve cells throughout the body due to an accumulation of glycogen in the lysosome resulting from a deficiency of the lysosomal acid alpha-glucosidase […]

<div class=”container”> <a href=”https://www.compbio.com/wp-content/uploads/2018/02/broncho_D.png”><img class=”alignleft size-full wp-image-3742″ src=”https://www.compbio.com/wp-content/uploads/2018/02/broncho_D.png” alt=””/></a> <div class=”centered”>CBI Congratulates <br>Meridigen Biotech Co. Ltd<br>on their successful IND submission<br>for their project:<br><br> UMC119-01 (hUC-MSCs)<br>for the treatment of<br>Bronchopulmonary Dysplasia. <br> <br> <a href=”https://www.compbio.com/wp-content/uploads/2018/02/cbi-Bronchopulmonary.Dysplasia.pdf” class=”button”>VIEW NOW</a> <img alt=”” src=”https://www.compbio.com/wp-content/uploads/2018/02/redline.png”> </div> </div>

          CBI-In Vivo Efficacy Study Showing Comparative Advantage of Bacterial Infection Prevention with Zip-type Skin Closure Device vs. Subcuticular Sutures   “In Vivo Efficacy Study Showing Comparative Advantage of Bacterial Infection Prevention with Zip-type Skin Closure Device vs. Subcuticular Sutures.” Recently CBI conducted a study for Zipline Medical, Inc. in which […]